Key Data:
Project type
Pharmaceutical compound manufacture
Estimated investment
US$340m (S$600m)
Completion
April to July 2004
Key Players:
Lead contractor
Jacobs Engineering Group, Bovis Lend Lease, Nova Weigh
Others
RSP Architects and Engineers of Singapore
Output Chemicals:
Drug substances
Active pharmaceutical ingredients including gabapentin and pregabalin